; and (B) in carrying out the study required under subparagraph (A), give due regard to any comments received under that subparagraph. (2) Contents The study required under paragraph (1) shall include potential impacts on the research market for smaller issuers, including the following: (A) The availability of that research, including— (i) the number and types of firms that provide that research; (ii) the volume of that research over time; and (iii) competition in the research market. (B) Any unique challenges faced by minority-owned, women-owned, or veteran-owned small issuers in obtaining research coverage. (C) The impact on the availability of research coverage for small issuers due to rules of the Commission. (D) A cost-benefit analysis of regulatory options that will support research coverage of small entities and increase transparency in the cost of research provided by broker-dealers. (E) Impacts of the no-action determination on— (i) investors in— (I) registered investment companies and exempt investment funds; (II) pension funds; and (III) endowments; (ii) other asset owners; (iii) investment advisers; (iv) broker-dealers that provide both investment research and trading services; (v) independent investment advisers that do not provide trading services; (vi) broker-dealers that do not provide investment research; and (vii) other market participants, including issuers of securities. (F) Potential impacts of the expiration of the no-action determination on the parties described in subparagraph (E). (3) Report Not later than 18 months after the date of enactment of this Act, the Commission, or delegated staff of the Commission, shall submit to the Committee on Banking, Housing, and Urban Affairs of the Senate and the Committee on Financial Services of the House of Representatives a report containing the findings and conclusions from the study conducted under this subsection, including findings relating to the expiration of the no-action determination.